Measles deaths expose the danger of forgetting what vaccines achieved

Three deaths and more than 1,000 confirmed cases in England show how falling vaccination coverage is allowing a once-controlled disease to return.

Three measles-related deaths have been reported in England in 2026, including a child, another child whose death was linked to the long-term effects of infection, and an adult with an underlying immune condition, according to UK government data and reporting from The BMJ. The deaths have come as the country continues to experience a renewed rise in measles, a disease that many parents and caregivers may have never seen first-hand because vaccination has made it so much less common than it once was. That success, public health experts argue, is part of the problem: when a disease fades from view, the urgency of vaccinating against it can fade too.

The latest figures from the UK government show 1,030 laboratory-confirmed measles cases in England between 1 January and 12 October 2026, with most infections in children aged 10 and under and about half of cases in London. The same publication notes that the country lost its measles elimination status in January after evidence of sustained transmission in 2024. England recorded 958 confirmed cases in 2025, and officials said activity in 2026 was concentrated in London and the West Midlands.

The broader pattern is familiar to infectious-disease specialists. When vaccination coverage is high, diseases that once caused widespread illness, disability and death can appear to have vanished, even though they remain a real threat. That can make the risk of side effects from a vaccine feel more immediate than the risk of infection itself. Misinformation also plays a role, especially online, where misleading claims can spread quickly and find an audience among people already uneasy about pharmaceutical companies, government advice or restrictions on personal choice.

Claims that cleaner living conditions, better sanitation and improved nutrition made vaccines unnecessary contain a kernel of truth but do not match the history of measles and other vaccine-preventable diseases. Better sanitation helped curb illnesses spread through contaminated water, such as cholera and typhoid, and better healthcare improved survival in general. But measles did not disappear because sewage systems improved. Before the vaccine was introduced in Britain in 1968, England and Wales typically logged between 160,000 and 800,000 measles notifications a year, along with about 100 deaths annually. As vaccination took hold, those numbers fell sharply.

The same logic applies to other diseases. Global vaccination and surveillance helped eradicate smallpox, and the World Health Organization says wild poliovirus cases have fallen by more than 99% since 1988. A 2024 study estimated that vaccination programmes prevented 154 million deaths worldwide between 1974 and 2024, most of them in children under five. Public health researchers say herd immunity remains crucial, because one person’s decision to skip vaccination can affect others, particularly infants, pregnant women and people with weakened immune systems who may not be able to rely on their own protection.

Concerns about vaccine safety should not be dismissed, but they need to be put in context. Vaccines, like all medicines, can cause side effects, although most are minor, such as soreness or a short-lived fever. Serious reactions are very rare. Some anti-vaccine claims, including assertions that routine childhood combinations overwhelm the immune system or cause autism, have been repeatedly rejected by large studies. Public health specialists also argue that trust depends on honesty: people are more likely to accept vaccination when officials acknowledge uncertainty, explain benefits and risks clearly, and make it easy to get vaccinated. In their view, the return of measles is a warning that success can breed complacency, and complacency can allow a preventable disease to spread again.